BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
TECHSellZACKSBuy
R500#199 today
$61.15
+0.53% today · -1.71% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- BMY +0.53% on the last session vs SPY +0.74%: −0.2 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 29
Before the open · in 25 days
EPS estimate
$1.73
$1.59 to $1.92 · 21 analysts
Revenue estimate
$12.7B
$12.3B to $13.1B
Track record
8/8 beats
last 8 reports · moved ±4.3% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 BMO | 2Q2026 | $1.60 | $2.04 | +$0.44 (+27.7%) beat | $13.0B | +2.8% +1.1 vs SPY | -0.7% | +0.8% |
| Apr 30, 2026 BMO | 1Q2026 | $1.42 | $1.58 | +$0.16 (+11.2%) beat | $11.5B | +5.2% +4.2 vs SPY | +0.2% | -1.7% |
| Feb 5, 2026 BMO | 4Q2025 | $1.20 | $1.26 | +$0.06 (+4.6%) beat | $12.5B | +3.3% +4.5 vs SPY | +2.2% | +4.0% |
| Oct 30, 2025 BMO | 3Q2025 | $1.52 | $1.63 | +$0.11 (+7.6%) beat | $12.2B | +7.1% +8.2 vs SPY | +1.6% | +9.1% |
| Jul 31, 2025 BMO | $1.10 | $1.46 | +$0.36 (+32.7%) beat | — | -5.8% -5.4 vs SPY | -3.9% | -2.5% | |
| Apr 24, 2025 BMO | $1.50 | $1.80 | +$0.30 (+20.0%) beat | — | +0.3% -1.8 vs SPY | -1.2% | +3.4% | |
| Feb 6, 2025 BMO | $1.47 | $1.67 | +$0.20 (+13.6%) beat | — | -3.8% -4.2 vs SPY | -3.9% | -6.0% | |
| Oct 31, 2024 BMO | $1.50 | $1.80 | +$0.30 (+20.0%) beat | — | +5.9% +7.9 vs SPY | +2.2% | +5.0% | |
| Jul 26, 2024 BMO | $1.63 | $2.07 | +$0.44 (+27.0%) beat | — | +11.4% +10.3 vs SPY | +6.6% | +6.4% | |
| Apr 25, 2024 BMO | −$4.42 | −$4.40 | +$0.02 (+0.5%) beat | — | -8.5% -8.1 vs SPY | -3.0% | -9.5% | |
| Feb 2, 2024 BMO | $1.58 | $1.70 | +$0.12 (+7.6%) beat | — | +0.1% -1.0 vs SPY | +1.2% | +0.1% | |
| Oct 26, 2023 BMO | $1.77 | $2.00 | +$0.23 (+13.0%) beat | — | -6.4% -5.2 vs SPY | -4.7% | -9.4% | |
| Jul 27, 2023 BMO | $1.99 | $1.75 | −$0.24 (−12.1%) miss | — | -4.2% -3.6 vs SPY | -3.8% | -2.6% | |
| Apr 27, 2023 BMO | $1.97 | $2.05 | +$0.08 (+4.1%) beat | — | -0.6% -2.6 vs SPY | 0.0% | -2.0% | |
| Feb 2, 2023 BMO | $1.73 | $1.82 | +$0.09 (+5.2%) beat | — | +2.2% +0.7 vs SPY | -1.3% | +3.4% | |
| Oct 25, 2022 AMC | $1.83 | $1.99 | +$0.16 (+8.7%) beat | — | +2.3% +3.1 vs SPY | +0.4% | +6.8% | |
| Jul 27, 2022 BMO | $1.80 | $1.93 | +$0.13 (+7.2%) beat | — | +1.6% -1.0 vs SPY | -1.7% | -0.5% | |
| Apr 29, 2022 BMO | $1.90 | $1.96 | +$0.06 (+3.2%) beat | — | -2.5% +1.2 vs SPY | -4.4% | -1.2% | |
| Feb 4, 2022 BMO | $1.80 | $1.83 | +$0.03 (+1.7%) beat | — | +1.4% +1.0 vs SPY | -1.4% | +3.8% | |
| Oct 27, 2021 BMO | $1.92 | $2.00 | +$0.08 (+4.2%) beat | — | -3.0% -2.6 vs SPY | +0.2% | +0.7% | |
| Jul 28, 2021 BMO | $1.90 | $1.93 | +$0.03 (+1.6%) beat | — | — | — | — | |
| Apr 29, 2021 BMO | $1.81 | $1.74 | −$0.07 (−3.9%) miss | — | — | — | — | |
| Feb 4, 2021 BMO | $1.42 | $1.46 | +$0.04 (+2.8%) beat | — | — | — | — | |
| Nov 5, 2020 BMO | $1.49 | $1.63 | +$0.14 (+9.4%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $1.73 (21) | $1.59 – $1.92 | +6% | +7.9% | ▲16 ▼1 | $12.7B | +4% |
| Next quarter · Dec 31, 2026 | $1.60 (21) | $1.28 – $1.71 | +27% | +4.7% | — | $12.7B | +2% |
| Current year · Dec 31, 2026 | $6.95 (27) | $6.80 – $7.15 | +13% | +10.1% | ▲1 ▼0 | $49.8B | +3% |
| Next year · Dec 31, 2027 | $6.56 (28) | $5.87 – $7.63 | -6% | +6.1% | ▲2 ▼1 | $48.2B | -3% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.